跳至主要内容
临床试验/NCT07741357
NCT07741357尚未招募不适用

Phase II Multi-Site Randomized Controlled Trial Testing Integrated Kidney Palliative Care Compared With Usual Chronic Kidney Disease Care (Kidney RISE)

NYU Langone Health2 个研究点 分布在 1 个国家目标入组 280 人开始时间: 2027年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
280
试验地点
2
主要终点
Change in Integrated Palliative Care Outcome Scale - Renal (IPOS-Renal) Patient Version scores

研究概览

简要总结

The purpose of study is to investigate whether adding palliative care to usual chronic kidney disease (CKD) care improves symptoms and quality of life for people with CKD. The primary objectives are to 1) determine efficacy of Kidney Palliative Care (KPC) integrated with CKD care on symptom burden compared with usual CKD care, 2) identify clinical and demographic factors associated with differential responses to KPC, and 3) characterize participant and provider experiences with kidney care and factors influencing implementation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Receive care at nephrology clinics or dialysis centers associated with each site.
  • Have CKD stage IV, V (eGFR < 30 mL/min/1.73m2), or be receiving chronic dialysis
  • Speak Spanish or English, and report at IPOS-Renal score of ≥ 3 on a screening survey.
  • Willing to be randomized to either study arm and to comply with the study procedures for the assigned group.

排除标准

  • Unable to provide informed consent
  • Has received palliative care (inpatient or outpatient) in the last six months.
  • Enrolled in hospice
  • Has any urgent palliative care needs (i.e. severe pain, emotional distress) identified upon screening. Research staff will be trained to recognize these needs.
  • Non-English and Non-Spanish speakers to correspond with the populations most impacted by CKD in the US.
  • Pregnant individuals.

结局指标

主要结局

Change in Integrated Palliative Care Outcome Scale - Renal (IPOS-Renal) Patient Version scores

时间窗: Baseline, Week 12

The IPOS-Renal Patient Version includes 10 questions (scored 0-90), with sub-scores for physical symptoms (15 questions, range 0-60), psychological symptoms (four questions, range 0-16), and practical impact of CKD (four questions, range 0-14). Higher scores indicate a higher burden of symptoms and greater distress for the patient.

Change in Integrated Palliative Care Outcome Scale - Renal (IPOS-Renal) Patient Version scores

时间窗: Baseline, Week 24

The IPOS-Renal Patient Version includes 10 questions (scored 0-90), with sub-scores for physical symptoms (15 questions, range 0-60), psychological symptoms (four questions, range 0-16), and practical impact of CKD (four questions, range 0-14). Higher scores indicate a higher burden of symptoms and greater distress for the patient.

次要结局

  • Change in Kidney Disease Quality of Life 36-Item (KDQOL-36) Short-Form Survey(Baseline, Week 12)
  • Change in Kidney Disease Quality of Life 36-Item (KDQOL-36) Short-Form Survey(Baseline, Week 24)
  • Number of participants with advance care planning(Week 12)
  • Number of participants with advance care planning(Week 24)
  • Change in Patient Activation Measure-13 (PAM-13) scores(Baseline, Week 12)
  • Change in Patient Activation Measure-13 (PAM-13) scores(Baseline, Week 24)
  • Change in General Anxiety Disorder-7 (GAD-7) scores(Baseline, Week 12)
  • Change in General Anxiety Disorder-7 (GAD-7) scores(Baseline, Week 24)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验